Get the Stockscreener App
70.45
1.75%
+1.21
After Hours:
70.45
Utah Medical Products, Inc. Stock (UTMD) Forecast
The Utah Medical Products, Inc. (UTMD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $67.49, representing a -4.21% decrease from the current price of $70.45. The highest analyst price target is $74.31, and the lowest is $60.66.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month UTMD Price Target
Average 77.24
(+9.64% Upside)
Is Utah Medical Products, Inc. (UTMD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.35 | Neutral |
| STOCH(9,6) | 59.84 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.1626 | Buy |
| ADX(14) | 16.40 | Neutral |
| William %R | -7.362 | Sell |
| CCI(14) | 113.91 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
69.06
Buy
|
68.95
Buy
|
| MA20 |
68.10
Buy
|
68.65
Buy
|
| MA50 |
68.85
Buy
|
69.63
Buy
|
| MA100 |
73.32
Sell
|
72.74
Sell
|
| MA200 |
79.70
Sell
|
78.06
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, UTMD could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on UTMD, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.35 indicates that UTMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.84 indicates that UTMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that UTMD is oversold. This suggests that UTMD price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.4 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 113.91 indicates that UTMD is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term UTMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Utah Medical Products, Inc. financial reports and earnings history, Utah Medical Products, Inc. (UTMD) stock could reach $52.90 by 2030, $55.15 by 2040 and $16.51 by 2050. See the projected annual prices until 2050 of the Utah Medical Products, Inc. stock below:
- Utah Medical Products, Inc. (UTMD) is expected to reach an average price of $54.48 in 2035, with a high prediction of $59.45 and a low estimate of $47.52. This indicates an $-22.67% rise from the last recorded price of $70.45.
- Utah Medical Products, Inc. (UTMD) stock is projected to chart a bullish course in 2040, with an average price target of $51.02, representing an $-27.57% surge from its current level. The forecast ranges from a conservative $46.29 to a sky-high $55.15.
- Our analysts predict Utah Medical Products, Inc. (UTMD) to jump -68.16% by 2045, soaring from $21.41 to an average price of $22.43, potentially reaching $33.74. While $21.41 is the low estimate, the potential upside is significant.
- Utah Medical Products, Inc. (UTMD) stock is expected to climb by 2050, reaching an average of $12.20, a $-82.68% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.51 and $8.3183, respectively, highlighting the market's uncertainty.
Utah Medical Products, Inc. Stock (UTMD) Year by Year Forecast
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2024
Our forecast for UTMD stock price in 2024 now indicates an average price target of $76.11 with a high forecast of $92.94 and a low forecast of $59.28. The average prediction reflects an increase of +8.04% from the last recorded price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $72.60 | $60.66 | $74.31 | +3.06% |
| July, 2024 | $74.98 | $65.35 | $77.49 | +6.42% |
| August, 2024 | $73.07 | $72.93 | $82.26 | +3.72% |
| September, 2024 | $81.76 | $71.76 | $83.68 | +16.05% |
| October, 2024 | $76.90 | $74.09 | $85.28 | +9.16% |
| November, 2024 | $86.10 | $73.93 | $92.94 | +22.21% |
| December, 2024 | $89.40 | $80.39 | $90.93 | +26.90% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2025
Utah Medical Products, Inc. Stock (UTMD) is expected to reach an average price of $77.24 in 2025, with a high prediction of $95.27 and a low estimate of $59.20. This indicates an +9.64% rise from the last recorded price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $92.48 | $84.41 | $95.27 | +31.27% |
| February, 2025 | $76.49 | $76.49 | $92.06 | +8.57% |
| March, 2025 | $72.14 | $68.40 | $80.83 | +2.39% |
| April, 2025 | $75.09 | $59.20 | $81.22 | +6.58% |
| May, 2025 | $68.17 | $60.49 | $75.72 | -3.24% |
| June, 2025 | $68.58 | $60.97 | $76.85 | -2.65% |
| July, 2025 | $82.84 | $68.64 | $91.84 | +17.59% |
| August, 2025 | $66.29 | $65.41 | $85.37 | -5.90% |
| September, 2025 | $64.90 | $61.32 | $77.26 | -7.88% |
| October, 2025 | $67.22 | $64.66 | $70.24 | -4.58% |
| November, 2025 | $63.44 | $60.75 | $67.53 | -9.95% |
| December, 2025 | $66.63 | $62.48 | $69.57 | -5.42% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2026
The predicted value for Utah Medical Products, Inc. (UTMD) in 2026 is set at an average of $73.47. Estimates vary from a peak of $82.05 to a trough of $64.89, indicating an +4.29% surge from the present price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $74.13 | $64.89 | $74.22 | +5.22% |
| February, 2026 | $71.93 | $69.59 | $78.58 | +2.10% |
| March, 2026 | $72.56 | $66.04 | $74.63 | +3.00% |
| April, 2026 | $72.94 | $65.98 | $79.47 | +3.53% |
| May, 2026 | $70.84 | $67.64 | $77.77 | +0.56% |
| June, 2026 | $71.47 | $67.91 | $74.38 | +1.45% |
| July, 2026 | $72.49 | $70.08 | $73.99 | +2.90% |
| August, 2026 | $67.34 | $65.05 | $73.00 | -4.41% |
| September, 2026 | $69.86 | $66.55 | $72.06 | -0.84% |
| October, 2026 | $70.15 | $68.71 | $74.48 | -0.43% |
| November, 2026 | $72.80 | $69.42 | $73.83 | +3.33% |
| December, 2026 | $77.55 | $70.96 | $82.05 | +10.08% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Utah Medical Products, Inc. (UTMD) is $91.59, with a high forecast of $118.24 and a low forecast of $64.94. This indicates an +30.00% increase from the last price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $77.50 | $72.60 | $81.16 | +10.01% |
| February, 2027 | $99.98 | $77.97 | $101.57 | +41.91% |
| March, 2027 | $79.17 | $79.17 | $118.24 | +12.37% |
| April, 2027 | $76.56 | $73.96 | $86.64 | +8.68% |
| May, 2027 | $78.27 | $72.96 | $87.48 | +11.10% |
| June, 2027 | $74.16 | $70.03 | $85.43 | +5.27% |
| July, 2027 | $74.48 | $70.55 | $77.21 | +5.72% |
| August, 2027 | $73.67 | $70.37 | $76.66 | +4.57% |
| September, 2027 | $69.63 | $67.06 | $73.49 | -1.16% |
| October, 2027 | $68.43 | $65.78 | $72.08 | -2.87% |
| November, 2027 | $68.19 | $65.10 | $74.68 | -3.21% |
| December, 2027 | $80.15 | $64.94 | $80.45 | +13.76% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2028
In 2028, Utah Medical Products, Inc. (UTMD) is projected to reach an average price of $80.16, with a high projection of $94.63 and a low estimate of $65.69. This indicates an +13.78% rise from the last price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $72.47 | $72.47 | $81.93 | +2.86% |
| February, 2028 | $70.29 | $69.86 | $78.86 | -0.22% |
| March, 2028 | $74.59 | $65.69 | $83.03 | +5.88% |
| April, 2028 | $74.90 | $70.39 | $78.84 | +6.32% |
| May, 2028 | $78.70 | $71.25 | $94.63 | +11.71% |
| June, 2028 | $79.50 | $69.19 | $87.57 | +12.85% |
| July, 2028 | $75.07 | $72.21 | $81.71 | +6.56% |
| August, 2028 | $74.81 | $66.06 | $81.50 | +6.19% |
| September, 2028 | $77.21 | $72.32 | $82.31 | +9.59% |
| October, 2028 | $79.09 | $75.63 | $84.38 | +12.26% |
| November, 2028 | $80.47 | $75.12 | $81.15 | +14.22% |
| December, 2028 | $78.72 | $73.04 | $86.08 | +11.73% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2029
The 2029 price forecast for Utah Medical Products, Inc. Stock (UTMD) is $65.37 on average, with a high prediction of $85.01 and a low estimate of $45.73. This represents an -7.21% decrease from the previous price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $83.91 | $77.70 | $85.01 | +19.10% |
| February, 2029 | $78.02 | $76.48 | $84.55 | +10.75% |
| March, 2029 | $69.55 | $69.30 | $79.56 | -1.27% |
| April, 2029 | $68.97 | $68.97 | $74.85 | -2.10% |
| May, 2029 | $64.78 | $60.75 | $71.43 | -8.05% |
| June, 2029 | $70.79 | $64.69 | $73.65 | +0.48% |
| July, 2029 | $70.10 | $64.41 | $72.88 | -0.50% |
| August, 2029 | $65.15 | $65.14 | $71.66 | -7.52% |
| September, 2029 | $56.54 | $55.88 | $66.42 | -19.75% |
| October, 2029 | $54.62 | $54.05 | $58.06 | -22.47% |
| November, 2029 | $54.68 | $53.00 | $57.63 | -22.39% |
| December, 2029 | $50.46 | $45.73 | $55.38 | -28.37% |
Utah Medical Products, Inc. Stock (UTMD) Price Forecast for 2030
Utah Medical Products, Inc. Stock (UTMD) is expected to reach an average price of $60.09 in 2030, with a high forecast of $78.29 and a low forecast of $41.90. This signifies an -14.70% decrease from the last price of $70.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $45.88 | $41.90 | $52.90 | -34.87% |
| February, 2030 | $52.40 | $44.84 | $60.17 | -25.62% |
| March, 2030 | $57.99 | $48.97 | $58.93 | -17.69% |
| April, 2030 | $63.50 | $54.55 | $65.02 | -9.86% |
| May, 2030 | $61.70 | $59.51 | $68.13 | -12.42% |
| June, 2030 | $60.06 | $56.84 | $64.70 | -14.75% |
| July, 2030 | $67.64 | $58.83 | $75.88 | -3.99% |
| August, 2030 | $76.31 | $66.21 | $78.29 | +8.32% |
| September, 2030 | $66.42 | $64.60 | $76.09 | -5.73% |
| October, 2030 | $59.44 | $56.22 | $74.18 | -15.62% |
| November, 2030 | $52.42 | $44.69 | $63.97 | -25.59% |
| December, 2030 | $45.96 | $42.40 | $64.42 | -34.77% |
0.18%
0.56%
Cap:
|
Volume (24h):